CORC

在结果中检索

CORC

浏览/检索结果: 共10条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/04
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：38/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Li, X.;  Bi, L.;  Li, Y.;  He, L.;  Xu, H.
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：7/0  |  提交时间：2019/11/19
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. 期刊论文
Clinical and experimental rheumatology, 2018
作者:  Bi Liqi;  Li Yuhui;  He Lan;  Xu Huji;  Jiang Zhenyu
收藏  |  浏览/下载：21/0  |  提交时间：2019/11/19
Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study 期刊论文
ARTHRITIS & RHEUMATOLOGY, 2017, 卷号: 69
作者:  Bi, Liqi;  Li, Yuhui;  He, Lan;  Xu, Huji;  Gu, Jieruo
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study 期刊论文
ARTHRITIS & RHEUMATOLOGY, 2017, 卷号: 69
作者:  Bi, Liqi;  Li, Yuhui;  He, Lan;  Xu, Huji;  Gu, Jieruo
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/26
Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study 期刊论文
ARTHRITIS & RHEUMATOLOGY, 2017, 卷号: Vol.69
作者:  Bi, LQ;  Li, YH;  He, L;  Xu, HJ;  Gu, JR
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/28

©版权所有 ©2017 CSpace - Powered by CSpace